CYP 0.00% 25.0¢ cynata therapeutics limited

Fair Value Please, page-213

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    If business as normal, you would expect more operational updates than what has been so far 2019.

    They have promised 3 Phase 2 trials starting 2019 and of course the multiple other indications spruiked on twitter...and with nearly 2/3rds of the year gone, it looks to me Cynata have over promised yet again.

    I did not think 2019 would have been so lacklustre business wise. (apart from the Sumi DD)

    Lets see, but just really quiet for what should have been the best year yet for action.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.